Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 16, 2024

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Children and Adolescents Aged 5 to 17 Years

JAMA: The Journal of the American Medical Association

 

Additional Info

JAMA: The Journal of the American Medical Association
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
JAMA 2024 Feb 06;331(5)408-416, LR Feldstein, A Britton, L Grant, R Wiegand, J Ruffin, TM Babu, M Briggs Hagen, JL Burgess, AJ Caban-Martinez, HY Chu, KD Ellingson, JA Englund, KT Hegmann, Z Jeddy, AS Lauring, K Lutrick, ET Martin, C Mathenge, J Meece, CM Midgley, AS Monto, G Newes-Adeyi, L Odame-Bamfo, LEW Olsho, AL Phillips, RP Rai, S Saydah, N Smith, L Steinhardt, H Tyner, M Vandermeer, M Vaughan, SK Yoon, M Gaglani, AL Naleway

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading